ClinicalTrials.govpublic full text
Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
hcv infection, hepatitis c, chronic, treatment failure, peg interferon, (interferons/therapeutic use, interferon alfa-2a/adverse effects), ribavirin, (ribavirin/therapeutic use, ribavirin/adverse effects), amantadine, drug therapy, combination, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010143
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.